| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.92 | 0.002 | 0.963 | DNA synthesis inhibitor | 0.956 0.001 DBMET03187 0.734 0.004 DBMET03190 0.963 0.001 DBMET03188 0.868 0.002 DBMET03191 0.954 0.001 DBMET03189 | DBMET03188 | |
| 0.831 | 0.001 | 0.859 | DNA repair enzyme inhibitor | 0.859 0.001 DBMET03187 0.407 0.003 DBMET03190 0.751 0.001 DBMET03188 0.49 0.003 DBMET03191 0.708 0.002 DBMET03189 | DBMET03187 | |
| 0.767 | 0.002 | 0.767 | DNA methylase inhibitor | 0.765 0.002 DBMET03187 0.557 0.005 DBMET03190 0.728 0.002 DBMET03188 0.66 0.003 DBMET03191 0.704 0.003 DBMET03189 | ||
| 0.754 | 0.003 | 0.754 | NOS3 expression enhancer | 0.646 0.004 DBMET03187 0.735 0.003 DBMET03190 0.58 0.004 DBMET03188 0.609 0.004 DBMET03191 0.555 0.005 DBMET03189 | ||
| 0.735 | 0.001 | 0.914 | Antimetabolite | 0.874 0.001 DBMET03187 0.357 0.004 DBMET03190 0.914 0.001 DBMET03188 0.742 0.001 DBMET03191 0.896 0.001 DBMET03189 | DBMET03188 | |
| 0.7 | 0.002 | 0.7 | DNA methyltransferase I inhibitor | 0.293 0.029 DBMET03187 0.463 0.005 DBMET03190 0.176 0.083 DBMET03188 0.154 0.099 DBMET03191 0.143 0.112 DBMET03189 | ||
| 0.691 | 0.003 | 0.837 | RNA-directed DNA polymerase inhibitor | 0.81 0.001 DBMET03187 0.626 0.004 DBMET03190 0.837 0.001 DBMET03188 0.727 0.002 DBMET03191 0.807 0.001 DBMET03189 | DBMET03188 | |
| 0.664 | 0.007 | 0.683 | Immunomodulator | 0.618 0.01 DBMET03187 0.427 0.037 DBMET03190 0.683 0.006 DBMET03188 0.442 0.033 DBMET03191 0.653 0.008 DBMET03189 | DBMET03188 | |
| 0.657 | 0.001 | 0.792 | NADH dehydrogenase inhibitor | 0.752 0.001 DBMET03187 0.648 0.002 DBMET03190 0.767 0.001 DBMET03188 0.792 0.001 DBMET03191 0.751 0.001 DBMET03189 | DBMET03191 | |
| 0.625 | 0.003 | 0.695 | Adenylate cyclase inhibitor | 0.683 0.002 DBMET03187 0.502 0.005 DBMET03190 0.695 0.002 DBMET03188 0.648 0.003 DBMET03191 0.681 0.002 DBMET03189 | DBMET03188 | |
| 0.608 | 0.001 | 0.762 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.74 0 DBMET03187 0.483 0.001 DBMET03190 0.762 0 DBMET03188 0.638 0.001 DBMET03191 0.74 0 DBMET03189 | DBMET03188 | |
| 0.621 | 0.045 | 0.621 | Apoptosis agonist | 0.594 0.05 DBMET03187 0.486 0.079 DBMET03190 0.516 0.069 DBMET03188 0.548 0.061 DBMET03191 0.522 0.068 DBMET03189 | ||
| 0.545 | 0.003 | 0.659 | DNA polymerase I inhibitor | 0.623 0.002 DBMET03187 0.509 0.004 DBMET03190 0.659 0.002 DBMET03188 0.613 0.002 DBMET03191 0.652 0.002 DBMET03189 | DBMET03188 | |
| 0.52 | 0.002 | 0.83 | Argininosuccinate synthase inhibitor | 0.811 0.001 DBMET03187 0.416 0.002 DBMET03190 0.83 0 DBMET03188 0.772 0.001 DBMET03191 0.811 0.001 DBMET03189 | DBMET03188 | |
| 0.543 | 0.03 | 0.548 | Antibacterial | 0.548 0.029 DBMET03187 0.299 0.136 DBMET03190 0.526 0.034 DBMET03188 0.492 0.043 DBMET03191 0.538 0.031 DBMET03189 | DBMET03187 | |
| 0.51 | 0.002 | 0.643 | UDP-glucose 4-epimerase inhibitor | 0.582 0.001 DBMET03187 0.565 0.001 DBMET03190 0.594 0.001 DBMET03188 0.643 0.001 DBMET03191 0.582 0.001 DBMET03189 | DBMET03191 | |
| 0.494 | 0.006 | 0.641 | Cytidine deaminase inhibitor | 0.544 0.005 DBMET03187 0.439 0.008 DBMET03190 0.572 0.004 DBMET03188 0.641 0.004 DBMET03191 0.524 0.005 DBMET03189 | DBMET03191 | |
| 0.506 | 0.031 | 0.548 | Immunosuppressant | 0.548 0.021 DBMET03187 0.432 0.052 DBMET03190 0.512 0.03 DBMET03188 0.533 0.025 DBMET03191 0.494 0.035 DBMET03189 | DBMET03187 | |
| 0.464 | 0.005 | 0.609 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.545 0.003 DBMET03187 0.469 0.005 DBMET03190 0.609 0.002 DBMET03188 0.58 0.003 DBMET03191 0.592 0.003 DBMET03189 | DBMET03188 | |
| 0.486 | 0.031 | 0.57 | Immunostimulant | 0.57 0.02 DBMET03187 0.4 0.049 DBMET03190 0.555 0.022 DBMET03188 0.501 0.029 DBMET03191 0.529 0.025 DBMET03189 | DBMET03187 | |
| 0.45 | 0.003 | 0.668 | Carbamoyl phosphate synthetase inhibitor | 0.652 0.001 DBMET03187 0.308 0.004 DBMET03190 0.668 0.001 DBMET03188 0.613 0.001 DBMET03191 0.652 0.001 DBMET03189 | DBMET03188 | |
| 0.441 | 0.003 | 0.664 | Phosphofructokinase-1 inhibitor | 0.638 0.001 DBMET03187 0.361 0.004 DBMET03190 0.664 0.001 DBMET03188 0.585 0.002 DBMET03191 0.638 0.001 DBMET03189 | DBMET03188 | |
| 0.442 | 0.004 | 0.442 | Adenosine A1 receptor antagonist | 0.167 0.014 DBMET03187 0.255 0.008 DBMET03190 0.078 0.029 DBMET03188 0.097 0.024 DBMET03191 0.061 0.039 DBMET03189 | ||
| 0.47 | 0.035 | 0.573 | Vasodilator, peripheral | 0.402 0.055 DBMET03187 0.469 0.035 DBMET03190 0.42 0.049 DBMET03188 0.573 0.019 DBMET03191 0.359 0.07 DBMET03189 | DBMET03191 | |
| 0.43 | 0.005 | 0.43 | Peptidyltransferase inhibitor | 0.37 0.009 DBMET03187 0.377 0.009 DBMET03190 0.352 0.012 DBMET03188 0.325 0.017 DBMET03191 0.346 0.013 DBMET03189 | ||
| 0.393 | 0.002 | 0.793 | Thymidine kinase inhibitor | 0.664 0.001 DBMET03187 0.324 0.002 DBMET03190 0.793 0.001 DBMET03188 0.661 0.001 DBMET03191 0.758 0.001 DBMET03189 | DBMET03188 | |
| 0.372 | 0.004 | 0.372 | Adenosine A2a receptor antagonist | 0.073 0.035 DBMET03187 0.127 0.019 DBMET03190 | ||
| 0.357 | 0.004 | 0.357 | Adenosine A3 receptor antagonist | 0.093 0.03 DBMET03187 0.227 0.008 DBMET03190 0.075 0.05 DBMET03188 0.081 0.041 DBMET03191 | ||
| 0.382 | 0.032 | 0.382 | DNA damaging | 0.28 0.066 DBMET03187 0.264 0.073 DBMET03190 0.223 0.098 DBMET03188 0.223 0.098 DBMET03191 0.263 0.074 DBMET03189 | ||
| 0.346 | 0.01 | 0.408 | Alkylator | 0.408 0.007 DBMET03187 0.236 0.018 DBMET03190 0.362 0.009 DBMET03188 0.353 0.01 DBMET03191 0.4 0.008 DBMET03189 | DBMET03187 | |
| 0.334 | 0.005 | 0.334 | Adenosine A2 receptor antagonist | 0.059 0.049 DBMET03187 0.103 0.026 DBMET03190 | ||
| 0.324 | 0.001 | 0.362 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.217 0.002 DBMET03187 0.362 0.001 DBMET03190 0.12 0.002 DBMET03188 0.303 0.001 DBMET03191 0.091 0.002 DBMET03189 | DBMET03190 | |
| 0.321 | 0.006 | 0.486 | Adenylate kinase inhibitor | 0.473 0.002 DBMET03187 0.301 0.007 DBMET03190 0.486 0.002 DBMET03188 0.474 0.002 DBMET03191 0.473 0.002 DBMET03189 | DBMET03188 | |
| 0.318 | 0.005 | 0.763 | Glutamate dehydrogenase inhibitor | 0.734 0.002 DBMET03187 0.172 0.013 DBMET03190 0.763 0.002 DBMET03188 0.554 0.003 DBMET03191 0.733 0.002 DBMET03189 | DBMET03188 | |
| 0.351 | 0.054 | 0.351 | Vasodilator, coronary | 0.267 0.118 DBMET03187 0.316 0.075 DBMET03190 0.271 0.114 DBMET03188 0.263 0.121 DBMET03191 0.238 0.147 DBMET03189 | ||
| 0.331 | 0.035 | 0.331 | Interleukin agonist | 0.253 0.076 DBMET03187 0.295 0.05 DBMET03190 0.16 0.158 DBMET03188 0.245 0.083 DBMET03191 | ||
| 0.296 | 0.002 | 0.461 | Phosphoglycerate kinase inhibitor | 0.441 0.001 DBMET03187 0.122 0.005 DBMET03190 0.461 0.001 DBMET03188 0.27 0.003 DBMET03191 0.437 0.001 DBMET03189 | DBMET03188 | |
| 0.278 | 0.002 | 0.278 | Adenosine deaminase inhibitor | 0.195 0.002 DBMET03187 0.158 0.003 DBMET03190 0.195 0.002 DBMET03188 0.132 0.003 DBMET03191 0.177 0.002 DBMET03189 | ||
| 0.289 | 0.016 | 0.317 | Interleukin 6 antagonist | 0.23 0.028 DBMET03187 0.317 0.013 DBMET03190 0.183 0.053 DBMET03188 0.282 0.018 DBMET03191 0.169 0.065 DBMET03189 | DBMET03190 | |
| 0.323 | 0.085 | 0.323 | Transcription factor NF kappa B inhibitor | 0.198 0.171 DBMET03190 | ||
| 0.306 | 0.069 | 0.306 | Interleukin 2 agonist | 0.291 0.08 DBMET03190 | ||
| 0.248 | 0.023 | 0.323 | Alpha-N-acetylglucosaminidase inhibitor | 0.323 0.014 DBMET03190 | DBMET03190 | |
| 0.219 | 0.002 | 0.219 | Thymidine phosphorylase inhibitor | 0.159 0.002 DBMET03187 0.188 0.002 DBMET03190 0.101 0.003 DBMET03188 0.167 0.002 DBMET03191 0.087 0.003 DBMET03189 | ||
| 0.222 | 0.011 | 0.431 | DNA directed RNA polymerase inhibitor | 0.367 0.005 DBMET03187 0.164 0.02 DBMET03190 0.396 0.005 DBMET03188 0.373 0.005 DBMET03191 0.431 0.005 DBMET03189 | DBMET03189 | |
| 0.218 | 0.01 | 0.406 | Aminoacyl-tRNA synthetase inhibitor | 0.372 0.004 DBMET03187 0.172 0.014 DBMET03190 0.406 0.004 DBMET03188 0.363 0.005 DBMET03191 0.397 0.004 DBMET03189 | DBMET03188 | |
| 0.203 | 0.007 | 0.615 | Ornithine carbamoyltransferase inhibitor | 0.561 0.002 DBMET03187 0.127 0.012 DBMET03190 0.615 0.002 DBMET03188 0.435 0.003 DBMET03191 0.559 0.002 DBMET03189 | DBMET03188 | |
| 0.187 | 0.004 | 0.35 | Purinergic P2X1 antagonist | 0.327 0.001 DBMET03187 0.156 0.006 DBMET03190 0.35 0.001 DBMET03188 0.292 0.002 DBMET03191 0.326 0.001 DBMET03189 | DBMET03188 | |
| 0.189 | 0.006 | 0.482 | Biliverdin reductase inhibitor | 0.411 0.002 DBMET03187 0.19 0.006 DBMET03190 0.48 0.001 DBMET03188 0.482 0.001 DBMET03191 0.457 0.002 DBMET03189 | DBMET03191 | |
| 0.182 | 0.006 | 0.289 | Acyl-CoA dehydrogenase inhibitor | 0.281 0.002 DBMET03187 0.157 0.008 DBMET03190 0.289 0.002 DBMET03188 0.277 0.002 DBMET03191 0.281 0.002 DBMET03189 | DBMET03188 | |
| 0.243 | 0.067 | 0.311 | Cyclic AMP phosphodiesterase inhibitor | 0.311 0.038 DBMET03190 0.244 0.067 DBMET03191 | DBMET03190 | |
| 0.177 | 0.004 | 0.739 | Fumarate hydratase inhibitor | 0.704 0.001 DBMET03187 0.101 0.005 DBMET03190 0.739 0.001 DBMET03188 0.583 0.002 DBMET03191 0.703 0.001 DBMET03189 | DBMET03188 | |
| 0.214 | 0.042 | 0.214 | Protein kinase C nu inhibitor | |||
| 0.18 | 0.009 | 0.365 | Ribonucleotide reductase inhibitor | 0.257 0.005 DBMET03187 0.155 0.011 DBMET03190 0.345 0.004 DBMET03188 0.236 0.006 DBMET03191 0.365 0.003 DBMET03189 | DBMET03189 | |
| 0.159 | 0.014 | 0.159 | Thioredoxin inhibitor | 0.081 0.08 DBMET03187 0.13 0.025 DBMET03190 | ||
| 0.152 | 0.011 | 0.265 | Ribonucleoside-diphosphate reductase inhibitor | 0.196 0.007 DBMET03187 0.13 0.014 DBMET03190 0.24 0.005 DBMET03188 0.181 0.008 DBMET03191 0.265 0.004 DBMET03189 | DBMET03189 | |
| 0.184 | 0.046 | 0.34 | Hexokinase inhibitor | 0.315 0.009 DBMET03187 0.142 0.088 DBMET03190 0.34 0.007 DBMET03188 0.337 0.007 DBMET03191 0.308 0.01 DBMET03189 | DBMET03188 | |
| 0.256 | 0.121 | 0.317 | Cholesterol antagonist | 0.317 0.08 DBMET03190 | DBMET03190 | |
| 0.159 | 0.024 | 0.474 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.315 0.005 DBMET03187 0.267 0.008 DBMET03190 0.349 0.005 DBMET03188 0.474 0.003 DBMET03191 0.314 0.005 DBMET03189 | DBMET03191 | |
| 0.216 | 0.086 | 0.216 | Angiogenesis stimulant | 0.186 0.102 DBMET03190 | ||
| 0.158 | 0.029 | 0.158 | Interleukin 8 antagonist | 0.129 0.05 DBMET03190 | ||
| 0.129 | 0.001 | 0.197 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.026 0.006 DBMET03187 0.197 0.001 DBMET03190 0.02 0.018 DBMET03188 0.036 0.004 DBMET03191 | DBMET03190 | |
| 0.127 | 0.004 | 0.237 | Thymidylate synthase inhibitor | 0.237 0.002 DBMET03187 0.076 0.009 DBMET03190 0.164 0.003 DBMET03188 0.184 0.003 DBMET03191 0.143 0.003 DBMET03189 | DBMET03187 | |
| 0.163 | 0.042 | 0.163 | MAP3K9 inhibitor | 0.147 0.064 DBMET03190 | ||
| 0.151 | 0.032 | 0.246 | Mucolytic | 0.176 0.02 DBMET03187 0.144 0.036 DBMET03190 0.226 0.009 DBMET03188 0.185 0.017 DBMET03191 0.246 0.007 DBMET03189 | DBMET03189 | |
| 0.132 | 0.016 | 0.25 | Purinergic P2X2 antagonist | 0.23 0.004 DBMET03187 0.25 0.003 DBMET03188 0.195 0.005 DBMET03191 0.245 0.003 DBMET03189 | DBMET03188 | |
| 0.159 | 0.049 | 0.19 | Adenylate cyclase stimulant | 0.156 0.053 DBMET03187 0.165 0.041 DBMET03190 0.128 0.107 DBMET03188 0.19 0.019 DBMET03191 | DBMET03191 | |
| 0.146 | 0.037 | 0.321 | Expectorant | 0.211 0.018 DBMET03187 0.135 0.042 DBMET03190 0.289 0.009 DBMET03188 0.223 0.016 DBMET03191 0.321 0.007 DBMET03189 | DBMET03189 | |
| 0.126 | 0.024 | 0.126 | Interleukin 12 antagonist | 0.101 0.053 DBMET03187 | ||
| 0.125 | 0.023 | 0.154 | Transcription factor NF kappa B stimulant | 0.136 0.019 DBMET03187 0.102 0.037 DBMET03190 0.154 0.015 DBMET03188 0.121 0.025 DBMET03191 0.148 0.016 DBMET03189 | DBMET03188 | |
| 0.097 | 0.003 | 0.122 | Adenosine kinase inhibitor | 0.115 0.003 DBMET03187 0.075 0.004 DBMET03190 0.122 0.003 DBMET03188 0.1 0.003 DBMET03191 0.105 0.003 DBMET03189 | DBMET03188 | |
| 0.097 | 0.003 | 0.148 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.14 0.001 DBMET03187 0.072 0.005 DBMET03190 0.148 0.001 DBMET03188 0.113 0.002 DBMET03191 0.14 0.001 DBMET03189 | DBMET03188 | |
| 0.091 | 0.003 | 0.153 | Uridine phosphorylase inhibitor | 0.099 0.002 DBMET03187 0.124 0.002 DBMET03190 0.08 0.003 DBMET03188 0.153 0.001 DBMET03191 0.074 0.004 DBMET03189 | DBMET03191 | |
| 0.126 | 0.038 | 0.129 | Protein kinase C mu inhibitor | 0.129 0.037 DBMET03190 | DBMET03190 | |
| 0.106 | 0.024 | 0.106 | Interferon agonist | |||
| 0.217 | 0.138 | 0.217 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.083 | 0.004 | 0.083 | Adenosine A1 receptor agonist | 0.055 0.005 DBMET03187 0.072 0.004 DBMET03190 0.048 0.006 DBMET03188 0.053 0.005 DBMET03191 0.046 0.006 DBMET03189 | ||
| 0.169 | 0.091 | 0.169 | Hepatoprotectant | 0.157 0.102 DBMET03190 | ||
| 0.088 | 0.011 | 0.445 | Purinergic P2Y antagonist | 0.33 0.003 DBMET03187 0.093 0.01 DBMET03190 0.424 0.002 DBMET03188 0.377 0.003 DBMET03191 0.445 0.002 DBMET03189 | DBMET03189 | |
| 0.105 | 0.028 | 0.25 | HIV-1 reverse transcriptase inhibitor | 0.165 0.012 DBMET03187 0.06 0.059 DBMET03190 0.244 0.007 DBMET03188 0.143 0.015 DBMET03191 0.25 0.007 DBMET03189 | DBMET03189 | |
| 0.091 | 0.017 | 0.091 | Interferon inducer | |||
| 0.08 | 0.007 | 0.152 | AICAR transformylase inhibitor | 0.152 0.003 DBMET03187 0.045 0.028 DBMET03190 0.113 0.004 DBMET03188 0.097 0.005 DBMET03191 0.101 0.005 DBMET03189 | DBMET03187 | |
| 0.092 | 0.02 | 0.092 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.071 | 0.003 | 0.071 | Adenosine A2 receptor agonist | 0.017 0.01 DBMET03187 0.031 0.005 DBMET03190 | ||
| 0.141 | 0.074 | 0.164 | Cell wall synthesis inhibitor | 0.164 0.052 DBMET03187 0.122 0.097 DBMET03191 | DBMET03187 | |
| 0.138 | 0.072 | 0.138 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.071 | 0.005 | 0.084 | Guanylate cyclase inhibitor | 0.082 0.003 DBMET03187 0.067 0.006 DBMET03190 0.084 0.002 DBMET03188 0.082 0.003 DBMET03191 0.082 0.003 DBMET03189 | DBMET03188 | |
| 0.17 | 0.106 | 0.17 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.157 0.123 DBMET03187 | ||
| 0.219 | 0.155 | 0.479 | Antithrombotic | 0.303 0.086 DBMET03187 0.261 0.117 DBMET03190 0.252 0.124 DBMET03188 0.479 0.032 DBMET03191 0.217 0.157 DBMET03189 | DBMET03191 | |
| 0.207 | 0.145 | 0.216 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.216 0.124 DBMET03190 | DBMET03190 | |
| 0.279 | 0.218 | 0.525 | Caspase 9 stimulant | 0.362 0.136 DBMET03187 0.386 0.12 DBMET03190 0.525 0.051 DBMET03191 | DBMET03191 | |
| 0.138 | 0.082 | 0.223 | Heat shock protein 70 antagonist | 0.207 0.005 DBMET03187 0.135 0.098 DBMET03190 0.223 0.005 DBMET03188 0.216 0.005 DBMET03191 0.205 0.005 DBMET03189 | DBMET03188 | |
| 0.115 | 0.059 | 0.119 | Topoisomerase I inhibitor | 0.119 0.056 DBMET03190 | DBMET03190 | |
| 0.084 | 0.03 | 0.378 | Purinergic P2 antagonist | 0.278 0.005 DBMET03187 0.355 0.004 DBMET03188 0.251 0.005 DBMET03191 0.378 0.004 DBMET03189 | DBMET03189 | |
| 0.062 | 0.008 | 0.062 | Antibiotic Aminoglycoside-like | 0.049 0.014 DBMET03187 0.059 0.009 DBMET03190 0.046 0.016 DBMET03188 0.047 0.015 DBMET03191 0.045 0.017 DBMET03189 | ||
| 0.054 | 0.002 | 0.183 | Purinergic P2Y1 agonist | 0.156 0.001 DBMET03187 0.041 0.002 DBMET03190 0.176 0 DBMET03188 0.147 0.001 DBMET03191 0.183 0 DBMET03189 | DBMET03189 | |
| 0.085 | 0.034 | 0.085 | MAP kinase kinase 7 inhibitor | |||
| 0.074 | 0.027 | 0.075 | Protein kinase C eta inhibitor | 0.075 0.026 DBMET03190 | DBMET03190 | |
| 0.159 | 0.118 | 0.159 | MAP kinase kinase 5 inhibitor | 0.155 0.133 DBMET03190 | ||
| 0.043 | 0.003 | 0.043 | Adenosine A2a receptor agonist | 0.02 0.008 DBMET03187 0.03 0.005 DBMET03190 | ||
| 0.047 | 0.01 | 0.161 | Purinergic P2X agonist | 0.126 0.002 DBMET03187 0.043 0.011 DBMET03190 0.161 0.002 DBMET03188 0.128 0.002 DBMET03191 0.155 0.002 DBMET03189 | DBMET03188 | |
| 0.042 | 0.006 | 0.042 | Purinergic P2Y15 antagonist | 0.038 0.008 DBMET03190 | ||
| 0.04 | 0.004 | 0.04 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.019 0.007 DBMET03187 0.029 0.005 DBMET03190 0.017 0.008 DBMET03188 0.018 0.008 DBMET03191 0.017 0.008 DBMET03189 | ||
| 0.236 | 0.201 | 0.575 | DNA directed DNA polymerase inhibitor | 0.339 0.143 DBMET03187 0.519 0.077 DBMET03188 0.575 0.062 DBMET03189 | DBMET03189 | |
| 0.061 | 0.026 | 0.064 | Alpha-mannosidase inhibitor | 0.064 0.022 DBMET03190 | DBMET03190 | |
| 0.038 | 0.003 | 0.038 | Isoleucine-tRNA ligase inhibitor | 0.021 0.02 DBMET03187 0.027 0.008 DBMET03190 | ||
| 0.063 | 0.029 | 0.063 | Protein 50S ribosomal subunit inhibitor | 0.062 0.029 DBMET03187 0.057 0.033 DBMET03190 0.055 0.035 DBMET03188 0.059 0.032 DBMET03191 0.052 0.037 DBMET03189 | ||
| 0.193 | 0.16 | 0.193 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.058 | 0.026 | 0.209 | Phosphorylase inhibitor | 0.11 0.012 DBMET03187 0.088 0.015 DBMET03190 0.18 0.006 DBMET03188 0.19 0.005 DBMET03191 0.209 0.005 DBMET03189 | DBMET03189 | |
| 0.055 | 0.023 | 0.1 | Glucose-6-phosphate isomerase inhibitor | 0.085 0.007 DBMET03187 0.06 0.018 DBMET03190 0.068 0.013 DBMET03188 0.1 0.005 DBMET03191 0.063 0.016 DBMET03189 | DBMET03191 | |
| 0.057 | 0.027 | 0.057 | Adenosine A2b receptor antagonist | |||
| 0.033 | 0.003 | 0.033 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.024 0.004 DBMET03187 0.023 0.005 DBMET03190 0.023 0.005 DBMET03188 0.017 0.012 DBMET03191 0.022 0.005 DBMET03189 | ||
| 0.052 | 0.024 | 0.053 | Mannosidase inhibitor | 0.053 0.023 DBMET03190 | DBMET03190 | |
| 0.029 | 0.005 | 0.029 | Adenosine A3 receptor agonist | 0.019 0.009 DBMET03187 0.026 0.006 DBMET03190 0.018 0.011 DBMET03188 0.018 0.01 DBMET03191 0.017 0.012 DBMET03189 | ||
| 0.027 | 0.005 | 0.531 | Purinergic P2 agonist | 0.088 0.002 DBMET03187 0.031 0.004 DBMET03190 0.378 0.001 DBMET03188 0.099 0.001 DBMET03191 0.531 0.001 DBMET03189 | DBMET03189 | |
| 0.027 | 0.005 | 0.531 | Purinergic receptor agonist | 0.088 0.002 DBMET03187 0.031 0.004 DBMET03190 0.378 0.001 DBMET03188 0.099 0.001 DBMET03191 0.531 0.001 DBMET03189 | DBMET03189 | |
| 0.099 | 0.078 | 0.099 | Protein kinase C gamma inhibitor | |||
| 0.109 | 0.089 | 0.136 | Amylase inhibitor | 0.136 0.071 DBMET03190 | DBMET03190 | |
| 0.024 | 0.004 | 0.038 | Methylmalonyl-CoA mutase inhibitor | 0.036 0.001 DBMET03187 0.022 0.005 DBMET03190 0.038 0.001 DBMET03188 0.036 0.002 DBMET03191 0.036 0.001 DBMET03189 | DBMET03188 | |
| 0.111 | 0.092 | 0.118 | Lck kinase inhibitor | 0.118 0.087 DBMET03187 | DBMET03187 | |
| 0.038 | 0.019 | 0.099 | Purinergic P2X3 antagonist | 0.058 0.009 DBMET03187 0.084 0.005 DBMET03188 0.099 0.004 DBMET03189 | DBMET03189 | |
| 0.123 | 0.105 | 0.151 | Acetylcholine M1 receptor antagonist | 0.151 0.073 DBMET03188 0.126 0.1 DBMET03189 | DBMET03188 | |
| 0.02 | 0.002 | 0.109 | Purinergic P2Y2 agonist | 0.038 0.001 DBMET03187 0.021 0.002 DBMET03190 0.085 0 DBMET03188 0.047 0.001 DBMET03191 0.109 0 DBMET03189 | DBMET03189 | |
| 0.023 | 0.005 | 0.023 | Adenosine A2b receptor agonist | 0.015 0.009 DBMET03187 0.02 0.006 DBMET03190 0.014 0.01 DBMET03188 0.014 0.011 DBMET03191 0.014 0.011 DBMET03189 | ||
| 0.021 | 0.005 | 0.523 | Purinergic P2Y agonist | 0.079 0.002 DBMET03187 0.025 0.004 DBMET03190 0.359 0.001 DBMET03188 0.09 0.001 DBMET03191 0.523 0.001 DBMET03189 | DBMET03189 | |
| 0.021 | 0.005 | 0.021 | Prokineticin receptor 1 antagonist | |||
| 0.067 | 0.054 | 0.069 | Protein kinase C beta inhibitor | 0.069 0.049 DBMET03190 | DBMET03190 | |
| 0.085 | 0.072 | 0.254 | Alcohol dehydrogenase inhibitor | 0.128 0.03 DBMET03187 0.216 0.011 DBMET03188 0.105 0.047 DBMET03191 0.254 0.007 DBMET03189 | DBMET03189 | |
| 0.017 | 0.004 | 0.019 | Purine nucleoside phosphorylase inhibitor | 0.018 0.004 DBMET03187 0.011 0.01 DBMET03190 0.019 0.003 DBMET03188 0.012 0.007 DBMET03191 0.017 0.004 DBMET03189 | DBMET03188 | |
| 0.024 | 0.011 | 0.082 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.069 0.003 DBMET03187 0.021 0.014 DBMET03190 0.082 0.003 DBMET03188 0.069 0.003 DBMET03191 0.078 0.003 DBMET03189 | DBMET03188 | |
| 0.093 | 0.081 | 0.123 | AMP-activated protein kinase stimulant | 0.123 0.046 DBMET03190 0.122 0.047 DBMET03191 | DBMET03190 | |
| 0.14 | 0.128 | 0.344 | Phospholipase C inhibitor | 0.341 0.015 DBMET03187 0.215 0.035 DBMET03188 0.344 0.015 DBMET03191 0.196 0.047 DBMET03189 | DBMET03191 | |
| 0.072 | 0.063 | 0.072 | Antineoplastic antibiotic | |||
| 0.052 | 0.044 | 0.057 | Glucosylceramidase inhibitor | 0.057 0.035 DBMET03190 | DBMET03190 | |
| 0.017 | 0.01 | 0.156 | Purinergic P2Y1 antagonist | 0.083 0.003 DBMET03187 0.016 0.011 DBMET03190 0.123 0.002 DBMET03188 0.091 0.003 DBMET03191 0.156 0.002 DBMET03189 | DBMET03189 | |
| 0.032 | 0.026 | 0.163 | Purinergic P2Y2 antagonist | 0.119 0.004 DBMET03187 0.041 0.015 DBMET03190 0.163 0.002 DBMET03188 0.139 0.003 DBMET03191 0.16 0.003 DBMET03189 | DBMET03188 | |
| 0.11 | 0.105 | 0.11 | Interleukin 1 antagonist | |||
| 0.023 | 0.018 | 0.023 | Protein 30S ribosomal subunit inhibitor | |||
| 0.004 | 0.002 | 0.03 | Purinergic P2Y6 agonist | 0.011 0.001 DBMET03187 0.005 0.001 DBMET03190 0.024 0 DBMET03188 0.017 0 DBMET03191 0.03 0 DBMET03189 | DBMET03189 | |
| 0.108 | 0.107 | 0.118 | Protein kinase stimulant | 0.11 0.105 DBMET03190 0.118 0.095 DBMET03191 | DBMET03191 | |
| 0.079 | 0.078 | 0.182 | Triose-phosphate isomerase inhibitor | 0.143 0.022 DBMET03187 0.088 0.063 DBMET03190 0.103 0.044 DBMET03188 0.182 0.013 DBMET03191 0.093 0.055 DBMET03189 | DBMET03191 | |
| 0.003 | 0.004 | 0.022 | Purinergic P2Y4 agonist | 0.012 0.001 DBMET03187 0.022 0.001 DBMET03188 0.015 0.001 DBMET03191 0.02 0.001 DBMET03189 | DBMET03188 | |
| 0.023 | 0.026 | 0.026 | Sodium/glucose cotransporter 2 inhibitor | 0.026 0.019 DBMET03190 | DBMET03190 | |
| 0.03 | 0.034 | 0.132 | Inosine monophosphate dehydrogenase inhibitor | 0.117 0.004 DBMET03187 0.132 0.004 DBMET03188 0.106 0.005 DBMET03191 0.112 0.005 DBMET03189 | DBMET03188 | |
| 0.087 | 0.098 | 0.125 | Folate antagonist | 0.125 0.035 DBMET03187 0.109 0.05 DBMET03188 0.105 0.057 DBMET03189 | DBMET03187 | |
| 0.021 | 0.035 | 0.026 | Sodium/glucose cotransporter inhibitor | 0.026 0.018 DBMET03190 | DBMET03190 | |
| 0.049 | 0.063 | 0.069 | Adenine nucleotide translocase inhibitor | 0.057 0.034 DBMET03187 0.059 0.03 DBMET03190 0.052 0.048 DBMET03188 0.069 0.017 DBMET03191 | DBMET03191 | |
| 0.12 | 0.134 | 0.143 | Interferon gamma antagonist | 0.143 0.087 DBMET03190 | DBMET03190 | |
| 0.011 | 0.027 | 0.194 | Purinergic P2T antagonist | 0.082 0.006 DBMET03187 0.194 0.004 DBMET03188 0.093 0.005 DBMET03191 0.165 0.004 DBMET03189 | DBMET03188 | |
| 0.011 | 0.033 | 0.077 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.065 0.004 DBMET03187 0.077 0.004 DBMET03188 0.057 0.004 DBMET03191 0.063 0.004 DBMET03189 | DBMET03188 | |
| 0.081 | 0.106 | 0.098 | Phosphodiesterase 6D inhibitor | 0.098 0.056 DBMET03190 | DBMET03190 | |
| 0.012 | 0.04 | 0.14 | Purinergic P2Y12 antagonist | 0.058 0.005 DBMET03187 0.116 0.004 DBMET03188 0.07 0.005 DBMET03191 0.14 0.004 DBMET03189 | DBMET03189 | |
| 0.039 | 0.069 | 0.081 | HIV-1 integrase (Strand Transfer) inhibitor | 0.081 0.031 DBMET03187 0.058 0.043 DBMET03188 0.073 0.034 DBMET03191 0.052 0.048 DBMET03189 | DBMET03187 | |
| 0.044 | 0.077 | 0.08 | HIV-1 integrase (3'-Processing) inhibitor | 0.08 0.034 DBMET03187 0.06 0.047 DBMET03188 0.072 0.037 DBMET03191 0.056 0.052 DBMET03189 | DBMET03187 | |
| 0.017 | 0.054 | 0.053 | HCV NS5B polymerase inhibitor | 0.044 0.012 DBMET03187 0.053 0.009 DBMET03188 0.048 0.01 DBMET03191 0.042 0.013 DBMET03189 | DBMET03188 | |
| 0.071 | 0.11 | 0.087 | Hematopoietic | 0.086 0.058 DBMET03187 0.087 0.055 DBMET03191 | DBMET03191 | |
| 0.137 | 0.177 | 0.303 | Vasodilator | 0.24 0.075 DBMET03187 0.215 0.093 DBMET03188 0.303 0.047 DBMET03191 0.252 0.068 DBMET03189 | DBMET03191 | |
| 0.069 | 0.126 | 0.117 | Anabolic | 0.096 0.068 DBMET03187 0.099 0.063 DBMET03188 0.117 0.042 DBMET03191 0.091 0.076 DBMET03189 | DBMET03191 | |
| 0.019 | 0.1 | 0.052 | RNA-directed RNA polymerase inhibitor | 0.042 0.017 DBMET03187 0.051 0.012 DBMET03188 0.052 0.012 DBMET03191 0.04 0.018 DBMET03189 | DBMET03191 | |
| 0.034 | 0.13 | 0.066 | Histidine decarboxylase inhibitor | 0.066 0.055 DBMET03191 | DBMET03191 | |
| 0.056 | 0.154 | 0.14 | Phosphodiesterase I inhibitor | 0.097 0.048 DBMET03187 0.14 0.02 DBMET03188 0.098 0.047 DBMET03191 0.117 0.029 DBMET03189 | DBMET03188 | |
| 0.071 | 0.173 | 0.243 | Aldehyde dehydrogenase inhibitor | 0.149 0.048 DBMET03187 0.243 0.019 DBMET03188 0.183 0.033 DBMET03191 0.203 0.027 DBMET03189 | DBMET03188 | |
| 0.028 | 0.135 | 0.058 | Carbonic anhydrase V inhibitor | 0.058 0.056 DBMET03191 | DBMET03191 | |
| 0.017 | 0.128 | 0.038 | Toll-Like receptor 4 agonist | 0.035 0.007 DBMET03187 0.032 0.009 DBMET03188 0.038 0.005 DBMET03191 0.031 0.01 DBMET03189 | DBMET03191 | |
| 0.03 | 0.161 | 0.088 | Antiviral (Hepatitis D) | 0.071 0.013 DBMET03187 0.088 0.006 DBMET03188 0.057 0.025 DBMET03191 0.086 0.007 DBMET03189 | DBMET03188 | |
| 0.065 | 0.197 | 0.127 | Src kinase inhibitor | 0.127 0.102 DBMET03187 | DBMET03187 | |
| 0.001 | 0.151 | 0.011 | Mannitol 2-dehydrogenase inhibitor | 0.01 0.004 DBMET03187 0.009 0.005 DBMET03188 0.011 0.004 DBMET03191 0.009 0.005 DBMET03189 | DBMET03191 | |
| 0.055 | 0.225 | 0.111 | Toll-Like receptor 4 antagonist | 0.111 0.054 DBMET03187 0.092 0.084 DBMET03188 0.111 0.054 DBMET03191 | DBMET03191 | |
| 0.069 | 0.25 | 0.124 | Transcription factor STAT6 inhibitor | 0.124 0.053 DBMET03191 | DBMET03191 | |
| 0.05 | 0.24 | 0.078 | Thioredoxin reductase inhibitor | 0.078 0.067 DBMET03188 | DBMET03188 | |
| 0.026 | 0.223 | 0.091 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.084 0.048 DBMET03188 0.091 0.043 DBMET03191 0.072 0.059 DBMET03189 | DBMET03191 | |
| 0.043 | 0.283 | 0.218 | Psychostimulant | 0.154 0.112 DBMET03187 0.218 0.071 DBMET03188 0.173 0.098 DBMET03191 0.175 0.096 DBMET03189 | DBMET03188 | |
| 0.06 | 0.327 | 0.219 | Platelet antagonist | 0.186 0.113 DBMET03188 0.155 0.14 DBMET03191 0.219 0.089 DBMET03189 | DBMET03189 | |
| 0.018 | 0.285 | 0.117 | Purinergic P2X4 antagonist | 0.049 0.026 DBMET03187 0.055 0.019 DBMET03188 0.117 0.004 DBMET03191 0.049 0.027 DBMET03189 | DBMET03191 | |
| 0.042 | 0.376 | 0.122 | Mannose-6-phosphate isomerase inhibitor | 0.122 0.097 DBMET03191 | DBMET03191 | |
| 0.006 | 0.365 | 0.95 | Somatostatin 4 antagonist | 0.95 0.001 DBMET03190 | DBMET03190 | |
| 0.043 | 0.423 | 0.204 | Platelet adhesion inhibitor | 0.204 0.069 DBMET03189 | DBMET03189 | |
| 0.045 | 0.438 | 0.316 | Insulin secretagoues | 0.158 0.067 DBMET03188 0.316 0.011 DBMET03189 | DBMET03189 | |
| 0.006 | 0.5 | 0.37 | Somatostatin 1 antagonist | 0.37 0.001 DBMET03190 | DBMET03190 | |
| 0.004 | 0.574 | 0.956 | Somatostatin 2 antagonist | 0.956 0.001 DBMET03190 | DBMET03190 | |
| 0.004 | 0.722 | 0.591 | Somatostatin 3 antagonist | 0.591 0.001 DBMET03190 | DBMET03190 | |
| 0.004 | 0.783 | 0.036 | Growth factor receptor-bound protein 2 antagonist | 0.036 0.023 DBMET03187 0.034 0.028 DBMET03188 0.036 0.021 DBMET03191 0.033 0.03 DBMET03189 | DBMET03191 | |
| 0.002 | 0.831 | 0.432 | Somatostatin 5 antagonist | 0.432 0.002 DBMET03190 | DBMET03190 | |
| 0.005 | 0.939 | 0.121 | Bone formation stimulant | 0.121 0.084 DBMET03191 | DBMET03191 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |